Healthcare provider profile · identity verified

Warren Mitchel Shaver, MD

Family Practice · HUNTINGTON, WV · NPI 1609838747

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	224	44
Atorvastatin Calcium	Atorvastatin Calcium	216	59
Lisinopril	Lisinopril	164	52
Gabapentin	Gabapentin	155	30
Losartan Potassium	Losartan Potassium	142	44
Hydrochlorothiazide	Hydrochlorothiazide	133	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	133	25
Amlodipine Besylate	Amlodipine Besylate	124	41
Furosemide	Furosemide	115	27
Metformin Hcl	Metformin Hcl	107	29
Omeprazole	Omeprazole	99	30
Metoprolol Succinate	Metoprolol Succinate	92	30
Tamsulosin Hcl	Tamsulosin Hcl	84	26
Fluticasone Propionate	Fluticasone Propionate	80	27
Famotidine	Famotidine	77	16
Pantoprazole Sodium	Pantoprazole Sodium	76	17
Duloxetine Hcl	Duloxetine Hcl	70	18
Albuterol Sulfate Hfa	Albuterol Sulfate	67	19
Rosuvastatin Calcium	Rosuvastatin Calcium	66	21
Tramadol Hcl	Tramadol Hcl	64	13
Lorazepam	Lorazepam	62	suppressed
Pravastatin Sodium	Pravastatin Sodium	56	20
Venlafaxine Hcl Er	Venlafaxine Hcl	55	12
Simvastatin	Simvastatin	54	16
Sertraline Hcl	Sertraline Hcl	52	14
Eliquis	Apixaban	48	14
Potassium Chloride	Potassium Chloride	48	11
Montelukast Sodium	Montelukast Sodium	47	suppressed
Alprazolam	Alprazolam	46	suppressed
Carvedilol	Carvedilol	44	suppressed
Trazodone Hcl	Trazodone Hcl	44	17
Buspirone Hcl	Buspirone Hcl	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	14
Metformin Hcl Er	Metformin Hcl	41	12
Clonazepam	Clonazepam	39	suppressed
Ibuprofen	Ibuprofen	39	suppressed
Jardiance	Empagliflozin	39	12
Allopurinol	Allopurinol	36	11
Meloxicam	Meloxicam	36	12
Atenolol	Atenolol	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Ozempic	Semaglutide	28	suppressed
Glimepiride	Glimepiride	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Mounjaro	Tirzepatide	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Naproxen	Naproxen	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Myrbetriq	Mirabegron	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Nabumetone	Nabumetone	19	suppressed
Spironolactone	Spironolactone	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Valproic Acid	Valproic Acid	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error